Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Interpace Diag Group (IDXG)

Interpace Diag Group (IDXG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Interpace Biosciences Expands Strategic Partnership Activities with Genecast Biotechnology in China

Further Strengthens Business Development Team with Key Hire

IDXG : 0.43 (-1.76%)
Interpace Biosciences Launches New Corporate Website

Interpace Biosciences, Inc. (IDXG) announced today that it is launching its new corporate website, "Interpace.com". Now both the Diagnostics and Pharma Solutions businesses of Interpace are represented...

IDXG : 0.43 (-1.76%)
Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results

Third Quarter Revenue Grew 34% Over the Prior Year's Quarter and 25% Year to Date

IDXG : 0.43 (-1.76%)
Interpace to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results on Wednesday, November 13, 2019

Interpace (IDXG) announced today that it will report its third quarter 2019 financial results on Wednesday, November 13, 2019 at 4:30 p.m. ET. Interpace will host a conference call and webcast to discuss...

IDXG : 0.43 (-1.76%)
Interpace Diagnostics Announces Publication of New Data on Thyroid Test Utility

Clinical Data Highlights the Utility of ThyGeNEXT and ThyraMIR

IDXG : 0.43 (-1.76%)
Interpace to Present Data at the ATA Annual Meeting

Interpace (IDXG) announced today that it will be presenting new data on the performance of its molecular thyroid products at the upcoming 89 Annual Meeting of the American Thyroid Association (ATA), being...

IDXG : 0.43 (-1.76%)
Cancer Genetics, Inc. Announces Strategic Transactions

Note Payment Received from Interpace Diagnostics Group, Inc.

CGIX : 6.99 (+26.86%)
IDXG : 0.43 (-1.76%)
Interpace to Present at the American College of Gastroenterology Conference

Interpace hosts 2 Annual Fellow Programs

IDXG : 0.43 (-1.76%)
Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners

Interpace Diagnostics Group, Inc. (IDXG) announced today that it has closed on a $13 million Convertible Preferred Stock investment by Ampersand Capital Partners (Ampersand). This investment constitutes...

CGIX : 6.99 (+26.86%)
IDXG : 0.43 (-1.76%)
Interpace Named to 'Most Admired Companies' List

Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has been named one of the 50 Most Admired Companies of the Year by The Silicon Review. The honorees are chosen by The Silicon Review's...

IDXG : 0.43 (-1.76%)
Interpace Announces New Contracts with Multiple Blue Cross Blue Shield Plans

In-Network Access for Thyroid Assays for More than 5 Million Members

IDXG : 0.43 (-1.76%)
Interpace to Present at The Ladenburg Thalmann 2019 Healthcare Conference

Interpace Diagnostics Group, Inc. ("Interpace" or the "Company") (NASDAQ: IDXG) today announced that the Company will present at the upcoming Ladenburg Thalmann 2019 Healthcare Conference, held on September...

IDXG : 0.43 (-1.76%)
Interpace Enters Strategic Partnership Agreement with Genecast Biotechnology to Partner with Biopharma Solutions in China

Interpace Diagnostics Group, Inc.'s subsidiary, Interpace BioPharma Inc. ("Interpace", "Interpace BioPharma" or the "Company") today announced that it has entered into a partnership agreement to jointly...

IDXG : 0.43 (-1.76%)
Interpace to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright

Interpace Diagnostics Group, Inc. ("Interpace" or the "Company") (NASDAQ: IDXG) today announced that the Company will present at the upcoming 21 Annual Global Investment Conference, sponsored by...

IDXG : 0.43 (-1.76%)
Predictive Oncology Inc. Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Predictive Oncology Inc., (NASDAQ: POAI) ("Predictive Oncology " or "the Company") an artificial intelligence (AI) and data-driven functional precision medicine company with the mission of improving the...

IDXG : 0.43 (-1.76%)
POAI : 3.01 (+0.33%)
Interpace Diagnostics Reports Second Quarter 2019 Financial Results and Provides Business Update

Second Quarter Revenue Grew 14% Over the Prior Year and 19% Year to Date Over the Prior Year

IDXG : 0.43 (-1.76%)
Interpace Diagnostics Group, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 13, 2019 / Interpace Diagnostics Group, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 13, 2019...

IDXG : 0.43 (-1.76%)
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2019 Financial Results on Tuesday, August 13, 2019

Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it will report its second quarter 2019 financial results on Tuesday, August 13, 2019 at 8:30 a.m. ET. Interpace will host a conference...

IDXG : 0.43 (-1.76%)
Interpace Diagnostics Announces Contract with Blue Cross Blue Shield of Michigan

In Network Access for More Than 6 Million Members

IDXG : 0.43 (-1.76%)
Predictive Oncology Subsidiary Helomics Executes Next Phase of Agreement with Interpace to Enhance the Diagnosis of Thyroid Cancer via AI-Driven Models

Predictive Oncology (Nasdaq: POAI) ("Predictive Oncology" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today its Helomics...

IDXG : 0.43 (-1.76%)
POAI : 3.01 (+0.33%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.46 , AIZ +1.17 , SBAC +0.55 , SO -0.62 , WELL -0.29
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar